MERRIMACK PHARMACEUTICALS INC·4

Jun 7, 4:47 PM ET

MERRIMACK PHARMACEUTICALS INC 4

4 · MERRIMACK PHARMACEUTICALS INC · Filed Jun 7, 2017

Insider Transaction Report

Form 4
Period: 2017-06-06
Drummond Daryl C
Head of Research
Transactions
  • Award

    Stock Option (right to buy)

    2017-06-06+450,000450,000 total
    Exercise: $1.45Exp: 2027-06-05Common Stock (450,000 underlying)
Footnotes (1)
  • [F1]This option vests as to 1/12th of the total number of shares granted on 9/6/17 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 6/6/20.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION